LyGenesis logo

LyGenesis Funding & Investors

Pittsburgh, PA

LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).

lygenesis.com

Total Amount Raised: $45,731,260

LyGenesis Funding Rounds

  • Series A

    $19,000,000

    Series A Investors

    Prime Movers Lab
    Juvenescence
  • Series Unknown

    $8,731,261

  • Convertible Note

    $11,000,000

    Convertible Note Investors

    Juvenescence
    Longevity Vision Fund
  • Debt Financing

    $4,000,000

    Debt Financing Investors

    Juvenescence
    Longevity Vision Fund
  • Series A

    $3,000,000

    Series A Investors

    Juvenescence
Funding info provided by Diffbot.